C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media

More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)

Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
12/2002
12/18/2002	EP1266965A2 Recombinant antibodies for human therapy
12/18/2002	EP0948349B1 in vitro methods and use of pharmaceutical compositions for the TREATMENT OF INNER EAR HAIR CELLS
12/18/2002	EP0811068B1 HUMAN DNase I VARIANTS
12/17/2002	US6495735 Transgenic non-human mammals expressing DNA sequences encoding homologous complement restriction factors of a discordant mammalian species
12/12/2002	WO2002061052A3 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
12/12/2002	US20020187208 Plant extract that inhibits the release of Tumor Necrosis Factor alpha (TNF-alpha)
12/11/2002	EP1263979A1 Method of purifying a fermentation broth
12/11/2002	EP1263963A2 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production
12/11/2002	EP1263790A1 Monoclonal antibodies to the human ldl receptor, their production and use
12/11/2002	EP1263780A2 Liv-1 related protein, polynulceotides encoding the same and use thereof for treatment of cancer
12/11/2002	CN1384878A IREN protein, its preparation and use
12/10/2002	CA2114015C Recombinant antibodies for human therapy
12/05/2002	WO2002097072A2 Influenza vaccine composition
12/05/2002	WO2002097061A2 Iterative promoter affinity chromatography to identify trans-regulatory networks of gene expression
12/05/2002	WO2002096262A2 Non-alloying core shell nanoparticles
12/05/2002	WO2001092487A9 Modified xylanases exhibiting increased thermophilicity and alkalophilicity
12/05/2002	US20020183937 Method for the generation of proteins with new enzymatic function
12/04/2002	EP1261718A2 Corynebacterium glutamicum genes encoding metabolic pathway proteins
12/04/2002	EP1261691A2 Serum free cultivation of primate embryonic stem cells
12/03/2002	US6489296 Treatment of hypercoagulable states or acquired protein c deficiency with activated protein c, a highly selective therapeutic agent with a low potential for causing bleeding complications
11/2002
11/28/2002	WO2002094997A2 Transcriptional regulation of target genes
11/28/2002	US20020177143 Non-alloying core shell nanoparticles
11/28/2002	US20020176868 Isolation and characterization of the csa operon (ETEC-CS4 pili) and methods of using same
11/27/2002	CN1094972C Lactobacillus strains of human origin, their compositions and uses thereof
11/21/2002	WO2002092778A2 Device and method for three-dimensional spatial localization and functional interconnection of different types of cells
11/21/2002	WO2002092774A2 Replicase cycling reaction amplification
11/21/2002	WO2002055098A3 Latency associated peptide for providing latency to pharmaceutically active proteins
11/21/2002	US20020173033 Device and method or three-dimensional spatial localization and functional interconnection of different types of cells
11/20/2002	EP1257649A2 Corynebacterium glutamicum genes encoding metabolic pathway proteins
11/20/2002	EP1257634A2 Method of making embryoid bodies from primate embryonic stem cells
11/20/2002	EP1257584A2 Humanized antibodies that sequester amyloid beta peptide
11/20/2002	EP1257282A1 Pancreatic stem cells and their use in transplantation
11/14/2002	US20020168669 Patterned polymer synthesis
11/13/2002	EP1255839A2 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
11/13/2002	CN1379813A Method to improve stability and broaden PH range of family G/11 xylanases
11/07/2002	US20020164802 Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer
11/07/2002	US20020164680 ErbB4 receptor-specific neuregulin related ligands and uses therefor
11/07/2002	US20020164606 Detecting polymorphisms in nucleotide sequence samples; obtain nucleotide sequence sample, incubate with primer, amplify, recover nucleotide sequences and analyze polymorphisms
11/06/2002	EP1254232A2 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation
11/06/2002	EP1254150A2 Nucleic acids, proteins, and antibodies
10/2002
10/31/2002	WO2002012502A3 Anti-tnf antibodies, compositions, methods and uses
10/24/2002	WO2002083919A2 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
10/24/2002	WO2002083860A2 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
10/24/2002	WO2002083854A2 Antibodies to vla-1
10/24/2002	WO2002083852A2 Microfermentor device and cell based screening method
10/24/2002	US20020156246 15625 receptor, a novel G-protein coupled receptor
10/24/2002	CA2443903A1 Antibodies to vla-1
10/24/2002	CA2443147A1 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
10/24/2002	CA2440785A1 Microfermentor device and cell based screening method
10/23/2002	EP1251173A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/17/2002	US20020151478 Fusion protein comprising a latency associated peptide and a proteolytic cleavage site wherein the fusion protein is associated with a pharmaceutically active agent; gene therapy; genetic engineering; antiinflammatory agents
10/17/2002	US20020151032 Generation of preferential viral vector; obtain cell, incubate with viral nucleotide sequences, propagate, recover nucleotide sequences
10/16/2002	EP1203075A4 Cell culture systems and methods for organ assist devices
10/10/2002	WO2002057287A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
10/10/2002	WO2002010343A3 Temperature-sensitive live vaccine for mycoplasma hyopneumoniae
10/10/2002	US20020147160 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
10/10/2002	US20020146691 Detecting gene asociated with preferential phenotype; obtain preferential nucleotide sequences, transduce cells, culture cells, recover cell of preferential phenotype, monitor gene expression in recovered cells
10/10/2002	US20020146435 In ovo vaccination against coccidiosis
10/10/2002	US20020146391 For diagnosis and therapy of susceptibility to atopic allergy, asthma
10/09/2002	EP1246946A2 Compositions and methods for the discovery and selection of biological information
10/09/2002	CN1373809A Streptomyces avermitilis gene directing ratio of B2:B1 avermectins
10/09/2002	CN1373804A Conditional immortalisation of cells
10/08/2002	CA2254145C Improved process to stabilize proteins
10/03/2002	WO2002077197A2 Methods for diagnosing and monitoring malignancies by screening gene copy numbers
10/03/2002	WO2002077194A2 Polymer synthesis
10/03/2002	US20020142460 Nervous system cells for use as model in the treatment of nervous system disorders
10/03/2002	US20020142389 Soluble T cell receptor
10/01/2002	US6458529 Assays for promoter operability in central nervous system cells
10/01/2002	CA1341389C Human granulocyte colony stimulating factor
09/2002
09/26/2002	WO2002074911A2 Identification of gene expression alterations underlying the aging process in mammals
09/26/2002	WO2002016611A3 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
09/26/2002	WO2001092487A3 Modified xylanases exhibiting increased thermophilicity and alkalophilicity
09/26/2002	US20020137927 Intermediates in the preparation of sidechain-bearing taxanes such as taxol and taxol derivatives.
09/26/2002	US20020137920 Magnetic pigment
09/26/2002	US20020137719 Particulate compositions for chemical synthesis
09/26/2002	US20020136978 Transfer of arrayed chemical compositions
09/26/2002	CA2441086A1 Identification of gene expression alterations underlying the aging process in mammals
09/25/2002	EP1243652A2 Glial derived neurotrophic factor
09/18/2002	EP1241258A2 Stem cell factor
09/18/2002	EP1137768A4 Human hybrid host cell for mammalian gene expression
09/18/2002	EP0789763B1 Icam-4 materials and methods
09/18/2002	CN1370239A Streptomyces avermitilis gene directing ratio of B2:B1 avermectins
09/17/2002	CA2113118C Novel growth factor-responsive progenitor cells which can be proliferated in vitro
09/11/2002	EP1237915A2 Polynucleotid encoding the rg1 polypeptide
09/11/2002	CN1090506C Application of lysozyme dimer
09/05/2002	US20020123091 Composition for use in the diagnosis, prevention and treatment of cardiovascular, endothelial or angiogenic disorders in mammals
09/05/2002	US20020123053 Methods for isolating centromere DNA
09/05/2002	US20020123034 Detecting preferential genetic disorders; obtain cells, transform with vector, recover clones, monitor clone for preferential gene expression, propagate clone expressing preferential genes, monitor killing genes
09/04/2002	EP1236045A2 Methods of using randomized libraries of zinc finger proteins for the identification of gene function
09/04/2002	EP0205475B2 Recombinant methods for production of serine protease inhibitors and dna sequences useful for same
09/04/2002	CN1090239C Recombinant virus vectors
09/04/2002	CN1090238C Process for producing enzyme
08/2002
08/29/2002	US20020119149 Multivalent T cell receptor complexes
08/22/2002	WO2002064748A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/22/2002	CA2438501A1 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/21/2002	EP1233065A1 G-CSF analog compositions and methods
08/21/2002	EP0537160B1 Expression of recombinant hemoglobin in yeast
08/15/2002	WO2002042429A3 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants
08/14/2002	EP1105537A4 Method for determining polynucleotide sequence variations
08/13/2002	US6433143 Tie-2 ligands

1 ... 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 ... 100